drugset
drugset / Trial / NCT02209831

Bioavailability of Oral BIRB 796 BS Tablets With and Without Administration of Oral Pantoprazole in Healthy Male Volunteers

NCT02209831 ↗

Phase 1 Completed 22 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

Study to assess the effect of gastric pH on the pharmacokinetics of BIRB 796 BS. Safety and tolerability were also assessed.

Timeline

Start
2001-11
Primary completion
2002-01
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject BIBR 796 BS Unknown 30 mg Oral
Subject Pantoprazole Other / unclassified — Oral

Indications

No indication recorded.